Cargando…
The case of galantamine: repurposing and late blooming of a cholinergic drug
Galantamine is a reversible inhibitor of cholinesterases and an allosteric modulator of neuronal nicotinic acetylcholine receptors which restores reduced cholinergic tone in the central and peripheral nervous system. Characterized in the early 1950s in Bulgaria, it saw limited use for paralytic and...
Autor principal: | Mucke, Hermann AM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137937/ https://www.ncbi.nlm.nih.gov/pubmed/28031923 http://dx.doi.org/10.4155/fso.15.73 |
Ejemplares similares
-
COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway
por: Ahmad, Farrukh
Publicado: (2020) -
Enhanced parasympathetic cholinergic activity with galantamine inhibited lipid-induced oxidative stress in obese African Americans
por: Parsa, Dena, et al.
Publicado: (2022) -
Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease
por: Baakman, Anne Catrien, et al.
Publicado: (2022) -
Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine
por: Crews, Fulton T., et al.
Publicado: (2021) -
The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial
por: Sangaleti, Carine Teles, et al.
Publicado: (2021)